Le Lézard
Classified in: Health, Science and technology, Business
Subject: BOARD OF DIRECTORS

Shareholders Elect New Board Member During Theratechnologies' Annual Meeting


MONTREAL, QUEBEC--(Marketwired - May 16, 2017) -

Editors Note: There is a photo associated with this press release.

Theratechnologies Inc. (TSX:TH) is pleased to announce the election of Dale Weil as a member of its Board.

Ms. Weil brings close to 35 years of business development experience, much of which was acquired while working with McKesson Canada, a diversified healthcare company and the largest pharmaceutical distributor in the country. At McKesson Canada, Ms. Weil has held various leadership positions, most recently as senior advisor to the president. Ms. Weil holds a Bachelor's degree in Marine Biology and a Master's degree in Business Administration, both from McGill University.

"I am sincerely honoured and thrilled to join Theratechnologies' Board of Directors. I have the privilege to join as the Company is about to potentially enter another transformational phase. I look forward to making a meaningful contribution to the Board and to support management in helping the Company reach new heights," said Ms. Weil.

"The election of Dale comes at a time when business development experience will be, more than ever, a valued asset within our board. I am most definitely looking forward to Dale's input and to have access to the tremendous experience she brings to our board," said Dawn Svoronos, Chair of the Board, Theratechnologies Inc.

About Theratechnologies

Theratechnologies (TSX:TH) is a specialty pharmaceutical company addressing unmet medical needs to promote healthy ageing and an improved quality of life among HIV patients. Further information about Theratechnologies is available on the Company's website at www.theratech.com and on SEDAR at www.sedar.com.

Forward-Looking Information

This press release contains statements that are considered forward-looking information ("FLI") within the meaning of securities regulation.

The FLI in this press release relates to future events or our future performance. The FLI are based on a number of assumptions and are associated with a number of risks, uncertainties and other unknown factors that may cause our actual results, levels of activity, performance or achievements to be materially different from those implied by the FLI. Such FLI reflects our current views with respect to future events and is given as at May 16, 2017. We undertake no obligation and do not intend to update or revise the FLI contained in this press release, except as required by law.

In preparing the FLI we have assumed, among other things, the following: (1) our increased promotional activities and presence within the medical community will increase our patient base in the United States and continue to grow EGRIFTA® sales in fiscal 2017; (2) ibalizumab will be approved in the United States as an HIV treatment; and (3) we will have the necessary infrastructure in place to successfully launch and commercialize ibalizumab in the United States.

The FLI in this press release may not materialize; accordingly, investors should not place undue reliance on it. We refer you to the "Risk Factors" section of our Annual Information Form dated February 7, 2017 available at www.sedar.com and at www.theratech.com for a description of the risks involved in the conduct of our business.

To view the photo associated with this press release, please visit the following link:

http://www.marketwire.com/library/20170516-Thera_2417_BB_lrg.jpg


These press releases may also interest you

at 04:00
Halfpricesoft.com offers a seamless and secure solution for in-house payroll processing with the l atest 2024 ezPaycheck YTD feature for those switching to the program, mid-year. The application is also combine d with features that have long...

at 04:00
U Power Limited (the "Company" or "U Power"), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider in China, today announced that the Company held an extraordinary general meeting of...

at 04:00
"The tourism data for Milan in 2023 reached an all-time high, and it's a success we must share among many stakeholders, both public and private, including the dense network of accommodation facilities in the city. We need virtuous examples like Hotel...

at 03:59
Timekettle, a fast-growing cross-language communication solutions innovator, has successfully wrapped up its #SpringTravelWithTimekettle campaign on Instagram. Running from March 18 to 24, Timekettle encouraged global travelers to share their...

at 03:52
The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can...

at 03:44
Bitrue, a leading cryptocurrency exchange serving over 10 million users globally, announces a focus on user behavior analysis to further develop the utility of its native token, Bitrue Coin (BTR). "Understanding how our users interact with BTR is...



News published on and distributed by: